Good Lifestyle

Over time, experts continue to collect data on how the protection provided by Covid vaccines from longer periods. Pfizer, Moderna and Johnson & Johnson have all found evidence suggesting that their vaccines continue to provide substantialProtection for up to six monthsBut there is still a question of what happens after that. Now, Pfizer says that immunity can not move over the time of the more infectious Delta variant and the company has announced that it would require an authorization for a third reminder plan for its vaccine in August.

RELATED:If you had a vaccine, get a reminder now, the virus expert warns.

In an announcement of July 8, Pfizer cited a study by the Israel Ministry of Health which found that the effectiveness of vaccines "in the prevention of infections and a symptomatic disease hasdeclined six months after vaccination. "Meanwhile, the vaccine seems to remain effective in preventing a serious illness beyond six months. Pfizer has also noted the additional challenge that the delta variant poses in conjunction with a liaison immunity. Study July 5 in Israel. concluded that the vaccine against Pfizer isnot as effective against the delta variant as it is against other strains,Wall Street newspaper reported.

The study was carried out from the beginning of June in early July, while Israel knew an epidemic caused by theDelta variant. Israel's Ministry of Health indicated that overvoltage, the Pfizer vaccine wasonly 64% effective Against infection and 94% effective in preventing serious illness. It is a substantial drop in the initial effectiveness of Pfizer, which was 94% effective against any infection and 97% effective in preventing serious illness.

In the Declaration, Pfizer noted that the conclusions of the Israel study are in line with the ongoing analysis of society. "That's why we said, and we continue to believe that it is likely, based on the entire data we have so far, that a third dose may be necessary within six to 12 months after vaccination Total ", the statement reads.

The recipients of Pfizer remain strongly protected against a serious COVID illness for six months, but according to the declaration, the emergence of variants and a natural decrease in symptomatic disease effectiveness should occur, which could lead to the need for the need for a third dose. "Based on the entire data they have so far, Pfizer and Biontech believe that a third dose can be beneficial to maintain the highest levels of protection," says the declaration.

RELATED:For more information up to date, sign up for our daily newsletter.

PfizerMikael Dolsten, PhD, told the associated press that the company's firing data from the companystudy suggests People's antibody levels could jump five to 10 times after a third dose. While Pfizer seems certain that they want to send third shots, regulators are not so convinced. By CNN, the Food and Drug Administration (FDA) and the Disease and Prevention Centers (CDC) published a joint statement saying: "Americans who have been completely vaccinateddoes not need a booster right now."

On 9 June, the World Health Organization (WHO) also told CNN: "We do not know whether recall vaccines will be needed to maintain protection against Covid-19 until additional data are collected . " The Organization noted that there are "limited data available over the duration of the duration of the current dose protection and whether an additional recall dose would be beneficial and for whom".

RELATED:If you did this after your first shot, you are at risk of the delta variant.